Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of CHANDAN
Quarter-by-quarter operating performance
| Dec 2024 | Sep 2025 | Dec 2025 | |
|---|---|---|---|
| Sales + | 54.64 | 67.90 | 65.01 |
| Expenses + | 45.75 | 53.75 | 53.17 |
| Operating Profit | 8.89 | 14.15 | 11.84 |
| OPM % | 16.27% | 20.84% | 18.21% |
| Other Income + | 0.17 | 0.84 | -1.46 |
| Interest | 1.09 | 1.40 | 1.28 |
| Depreciation | 1.35 | 2.46 | 2.40 |
| Profit before tax | 6.62 | 11.13 | 6.70 |
| Tax % | 30.21% | 25.79% | 24.93% |
| Net Profit + | 4.20 | 7.80 | 4.54 |
| EPS in Rs | 2.10 | 3.19 | 1.86 |
Financials of CHANDAN
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Sales + | 120 | 137 | 177 | 230 |
| Expenses + | 117 | 128 | 150 | 189 |
| Operating Profit | 2 | 9 | 26 | 41 |
| OPM % | 2% | 7% | 15% | 18% |
| Other Income + | 0 | 0 | 1 | 2 |
| Interest | 2 | 2 | 3 | 5 |
| Depreciation | 2 | 2 | 3 | 7 |
| Profit before tax | -1 | 5 | 21 | 32 |
| Tax % | 3% | 28% | 24% | 27% |
| Net Profit + | -1 | 3 | 16 | 24 |
| EPS in Rs | -0.56 | 1.68 | 8.14 | 9.07 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
Financials of CHANDAN
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 7 | 21 | 98 | 114 |
| Borrowings + | 17 | 21 | 36 | 48 | 67 |
| Other Liabilities + | 41 | 49 | 41 | 40 | 68 |
| Total Liabilities | 82 | 98 | 118 | 211 | 273 |
| Fixed Assets + | 29 | 33 | 48 | 76 | 91 |
| CWIP | 0 | 0 | 0 | 4 | 5 |
| Investments | 6 | 7 | 3 | 1 | 47 |
| Other Assets + | 46 | 58 | 66 | 129 | 130 |
| Total Assets | 82 | 98 | 118 | 211 | 273 |
Financials of CHANDAN
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Cash from Operating Activity + | 6 | 4 | 1 | -29 |
| Cash from Investing Activity + | -11 | -6 | -15 | -36 |
| Cash from Financing Activity + | 3 | 2 | 16 | 67 |
| Net Cash Flow | -1 | 0 | 2 | 2 |
| Free Cash Flow | -1 | -1 | -18 | -68 |
| CFO/OP | 275% | 60% | 23% | -50% |
Financials of CHANDAN
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 88 | 63 | 59 | 74 |
| Inventory Days | 46 | 71 | 96 | 126 |
| Days Payable | 185 | 251 | 102 | 102 |
| Cash Conversion Cycle | -51 | -117 | 53 | 98 |
| Working Capital Days | -11 | -21 | -1 | 75 |
| ROCE % | 16% | 37% | 29% |
East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…
IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…
Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…